ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 117 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $436,642 | +4.0% | 187,400 | -14.8% | 0.53% | +16.4% |
| Q3 2022 | $420,000 | -29.5% | 220,000 | 0.0% | 0.46% | -24.3% |
| Q2 2022 | $596,000 | 0.0% | 220,000 | +10.0% | 0.60% | +65.8% |
| Q1 2022 | $596,000 | -43.2% | 200,000 | -25.9% | 0.36% | -22.6% |
| Q4 2021 | $1,050,000 | -28.0% | 270,000 | -20.6% | 0.47% | -11.5% |
| Q3 2021 | $1,459,000 | +41.7% | 340,000 | 0.0% | 0.53% | +55.9% |
| Q2 2021 | $1,030,000 | +18.9% | 340,000 | +30.8% | 0.34% | +1.5% |
| Q1 2021 | $866,000 | – | 260,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |